We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




TIAs Are Not Just Mild Strokes

By HospiMedica staff writers
Posted on 21 Feb 2002
A study has found that patients who have transient ischemic attacks (TIAs) have different risk profiles from those who have mild strokes, indicating a different cause and perhaps the need for different treatment. More...
The study was presented at the 27th International Stroke Conference in San Antonio (TX, USA).

Although the symptoms of stroke and TIAs are similar, TIAs don't leave any permanent disability. Danish researchers decided to look for differences in the causes of TIAs. Based on data from the Copenhagen Stroke Study, they compared the risk factor profiles and short- and long-term outcomes of 154 patients who had experienced TIAs with 482 patients who had experienced mild strokes. They did find differences. TIA patients were half as likely to have diabetes and half as likely to have narrowing of the leg arteries. If TIAs are not caused by blood clots, then aspirin therapy cannot help prevent them, note the researchers.

In spite of having different risk factors, both TIAs and strokes can be deadly. Short-term mortality rates indicated that 1.3% of TIA patients died, as did 2.3% of patients with minor strokes. However, after five years, the survival rates were virtually the same for both.

"It is clear that many transient ischemic attacks are due to blood clots,” said Tom S. Olsen, M.D., Ph.D., chairman of the department of neurology, Gentofte University Hospital (Hellerup, Denmark). "But it could be that some of them are due to spasm of brain arteries instead of a clot.”

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.